 So hello everyone, my name is Hong and I'm just here to accept this on behalf of Dr. Jones and Dr. Morakoff and Professor Drummond. They are all in San Francisco at the moment to present our work at the annual conference. So here are a few, so first of all I would like to thank the Brain Foundation, the committee, Professor Kinen and all the members and the donors for the Brain Foundations. Our work at the moment focusing on the glioplastoma. So approximately each year there are 2000 Australian suffer from brain cancer. Apart from that, the most common type of brain cancer is glioplastoma. It's a devastating disease with 20% of each, 20% of the disease patients surviving beyond five years is only 20%. The current methods of diagnosing and monitoring glioplastoma is through MRI. However MRIs, although it gives you good anatomic and spatial information about a tumor, it is not reliable at predicting how the tumor is going to behave in the future. So it is not accurate enough to detect early tumor recurrence in many patients. So we propose that instead of having an MRI scan, we having also a blood test. So what it does is that a blood test is non-invasive and it can help you monitor the tumor as it progress through the tumor treatment progressions. So a blood test has the potential to solve these challenges. Circulating biomarkers are starting to be integrated in the care of breast cancer and colorectal cancer, but up to date there's not been any study that using blood circulating biomarkers to validate brain cancer. So in our lab we have up to date identified a panel of nine circulating biomarkers that we can show that between brain tumors and healthy control there's 99% accuracy that can predict from brain tumor. So with the help of this funding here, we plan to use these nine markers to monitor it alongside with the MRI scan so that we can predict when the tumor can come back and so we can manage the treatments and the treatment plan for each patient better. So we also investigate these along with the MRI like I said. So thank you so much for the foundations and all the members for the funding for this work.